-
1.发明申请PROCESS FOR PREPARING PRODUCTS COMPRISING STABILISED ACTIVES AND COMPOSITIONS COMPRISING SAME 审中-公开制备包含稳定活性的产品的方法和包含其的组合物公开(公告)号：US20150342886A1
公开(公告)日：2015-12-03
申请号：US14586548
申请日：2014-12-30
Applicant: Sai Ying Ko
Inventor： Sai Ying Ko
CPC classification number: B01J13/043 , A23K40/30 , A23P10/30 , A61K9/006 , A61K9/1676 , A61K9/1682 , A61K9/2081 , A61K38/1816 , A61K38/193 , A61K38/20 , A61K38/21 , A61K38/22 , A61K38/27 , B05D1/02
Abstract: The present invention broadly relates to a process for preparing products comprising active components, and in particular biological materials, wherein the active components are stabilised. The invention further relates to compositions comprising the products, and in particular compositions comprising therapeutic biological materials.
Abstract translation: 本发明广泛地涉及一种制备包含活性组分，特别是其中活性组分稳定的生物材料的产品的方法。 本发明还涉及包含产品的组合物，特别是包含治疗性生物材料的组合物。
-
Patent Agency Ranking
公开(公告)号：US09248188B2
公开(公告)日：2016-02-02
申请号：US13885993
申请日：2011-11-09
Applicant: Sai Ying Ko
Inventor： Sai Ying Ko
Abstract: Provided herein are methods for the treatment of abnormal inflammation and inflammatory conditions comprising mucosal administration of an effective amount of an interleukin (e.g. IL-2) or a fragment or derivative thereof. Also provided herein are pharmaceutical compositions for mucosal administration for the treatment of abnormal inflammation and inflammatory conditions, the composition comprising said interleukin or fragment or derivative.
-
3.发明申请PROCESS FOR PREPARING PRODUCTS COMPRISING STABILISED ACTIVES AND COMPOSITIONS COMPRISING SAME 有权制备包含稳定活性的产品的方法和包含其的组合物公开(公告)号：US20120219624A1
公开(公告)日：2012-08-30
申请号：US13320520
申请日：2011-02-18
Applicant: Sai Ying Ko
Inventor： Sai Ying Ko
IPC: A61K9/14 , A61K9/22 , A61K9/20 , A61P35/00 , A61P29/00 , B05C5/00 , A61P3/10 , A61P37/08 , A61P31/10 , B05D1/02 , B05D3/02 , A61K9/50 , A61P7/00
CPC classification number: B01J13/043 , A23K40/30 , A23P10/30 , A61K9/006 , A61K9/1676 , A61K9/1682 , A61K9/2081 , A61K38/1816 , A61K38/193 , A61K38/20 , A61K38/21 , A61K38/22 , A61K38/27 , B05D1/02
Abstract: The present invention broadly relates to a process for preparing products comprising active components, and in particular biological materials, wherein the active components are stabilised. The invention further relates to compositions comprising the products, and in particular compositions comprising therapeutic biological materials.
Abstract translation: 本发明广泛地涉及一种制备包含活性组分，特别是其中活性组分稳定的生物材料的产品的方法。 本发明还涉及包含产品的组合物，特别是包含治疗性生物材料的组合物。
-
4.发明授权Method for treating inflammatory conditions with mucosally administered interleukin-2 有权用粘膜给药白介素-2治疗炎性病症的方法公开(公告)号：US09289493B2
公开(公告)日：2016-03-22
申请号：US13885993
申请日：2011-11-09
Applicant: Sai Ying Ko
Inventor： Sai Ying Ko
CPC classification number: A61K45/06 , A61K9/0053 , A61K9/0056 , A61K9/006 , A61K9/1623 , A61K9/2086 , A61K9/4858 , A61K38/20 , A61K38/2013
Abstract: Provided herein are methods for the treatment of abnormal inflammation and inflammatory conditions comprising mucosal administration of an effective amount of an interleukin (e.g. IL-2) or a fragment or derivative thereof. Also provided herein are pharmaceutical compositions for mucosal administration for the treatment of abnormal inflammation and inflammatory conditions, the composition comprising said interleukin or fragment or derivative.
Abstract translation: 本文提供了治疗异常炎症和炎性病症的方法，包括粘膜施用有效量的白细胞介素（例如IL-2）或其片段或衍生物。 本文还提供了用于治疗异常炎症和炎性病症的粘膜给药的药物组合物，所述组合物包含所述白细胞介素或片段或衍生物。
-
5.发明授权Process for preparing products comprising stabilised actives and compositions comprising same 有权制备包含稳定的活性物质和包含其的组合物的方法公开(公告)号：US08951566B2
公开(公告)日：2015-02-10
申请号：US13320520
申请日：2011-02-18
Applicant: Sai Ying Ko
Inventor： Sai Ying Ko
IPC: A61K9/14 , A61K9/16 , A61K9/28 , B01J13/00 , B05D3/00 , B01J13/04 , A23K1/00 , A61K38/18 , A61K38/19 , A61K38/20 , A61K38/21 , A61K38/27 , A61K9/20 , A23P1/04 , A23L1/00
CPC classification number: B01J13/043 , A23K40/30 , A23P10/30 , A61K9/006 , A61K9/1676 , A61K9/1682 , A61K9/2081 , A61K38/1816 , A61K38/193 , A61K38/20 , A61K38/21 , A61K38/22 , A61K38/27 , B05D1/02
Abstract: The present invention broadly relates to a process for preparing products comprising active components, and in particular biological materials, wherein the active components are stabilized. The invention further relates to compositions comprising the products, and in particular compositions comprising therapeutic biological materials.
Abstract translation: 本发明广泛地涉及一种制备包含活性组分，特别是其中活性组分稳定的生物材料的产品的方法。 本发明还涉及包含产品的组合物，特别是包含治疗性生物材料的组合物。
-
公开(公告)号：US20130315859A1
公开(公告)日：2013-11-28
申请号：US13885993
申请日：2011-11-09
Applicant: Sai Ying Ko
Inventor： Sai Ying Ko
CPC classification number: A61K45/06 , A61K9/0053 , A61K9/0056 , A61K9/006 , A61K9/1623 , A61K9/2086 , A61K9/4858 , A61K38/20 , A61K38/2013
Abstract: Provided herein are methods for the treatment of abnormal inflammation and inflammatory conditions comprising mucosal administration of an effective amount of an interleukin (e.g. IL-2) or a fragment or derivative thereof. Also provided herein are pharmaceutical compositions for mucosal administration for the treatment of abnormal inflammation and inflammatory conditions, the composition comprising said interleukin or fragment or derivative.
Abstract translation: 本文提供了治疗异常炎症和炎性病症的方法，包括粘膜施用有效量的白细胞介素（例如IL-2）或其片段或衍生物。 本文还提供了用于治疗异常炎症和炎性病症的粘膜给药的药物组合物，所述组合物包含所述白细胞介素或片段或衍生物。
-
-
-
-
-
Search Results
6
records
(took 0.016 seconds)
